MED

SEC source: 0001628280-25-013671 · wk-form4_1742347731.xml · nonDerivative · entry 2

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,566

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-25-013670 · wk-form4_1742347653.xml · nonDerivative · entry 2

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,576

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-25-013669 · wk-form4_1742347593.xml · nonDerivative · entry 2

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,157

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-25-013671 · wk-form4_1742347731.xml · nonDerivative · entry 1

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,626

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-25-013670 · wk-form4_1742347653.xml · nonDerivative · entry 1

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,699

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-25-013669 · wk-form4_1742347593.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,101

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-25-004896 · wk-form5_1739309448.xml · nonDerivative · entry 8

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · The Dan and Allyson Family Irrevocable Trust

Disclosed balance after: 149,317.352

F2 · ownership.nature: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.

SEC source: 0001628280-25-004896 · wk-form5_1739309448.xml · nonDerivative · entry 7

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Dan and Allyson as Joint Tenants

Disclosed balance after: 0

F5 · shares: On December 3, 2024, the reporting person transferred 149,317.352 shares of Medifast common stock to the Dan and Allyson Family Irrevocable Trust for no consideration. The reporting person is trustee of the trust, and the reporting person and members of his immediate family are the sole beneficiaries of the trust.

F3 · ownership.nature: These shares are directly owned by a joint account of which the reporting person owns as a joint tenant with his spouse.

SEC source: 0001628280-24-040661 · wk-form4_1726610779.xml · nonDerivative · entry 1

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,906

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-029661 · wk-form4_1719265842.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,960.647

F2 · shares: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation for annual service as a non-employee director of the Issuer.

F3 · price: This price per share of $22.66 is based on the 20-day moving average stock price of the Issuer's common stock as of June 18, 2024.

SEC source: 0001628280-24-029661 · wk-form4_1719265842.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,379.647

F1 · shares: 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.

SEC source: 0001628280-24-029660 · wk-form4_1719265793.xml · nonDerivative · entry 1

Thomas Andrea B · CIK 0001779769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,849.123

F1 · shares: 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.

SEC source: 0001628280-24-029659 · wk-form4_1719265760.xml · nonDerivative · entry 1

Geary Elizabeth A. · CIK 0001981550 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,377

F1 · shares: 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.

SEC source: 0001628280-24-029658 · wk-form4_1719265724.xml · nonDerivative · entry 1

Hoer Michael A. · CIK 0001743755 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,971.473

F1 · shares: 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.

SEC source: 0001628280-24-029657 · wk-form4_1719265691.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,380.707

F1 · shares: 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.

SEC source: 0001628280-24-029656 · wk-form4_1719265644.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,961.918

Underlying: Common Stock · 10,149 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

SEC source: 0001628280-25-004896 · wk-form5_1739309448.xml · nonDerivative · entry 5

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Dan and Allyson as Joint Tenants

Disclosed balance after: 149,317.352

F3 · ownership.nature: These shares are directly owned by a joint account of which the reporting person owns as a joint tenant with his spouse.

SEC source: 0001628280-25-004896 · wk-form5_1739309448.xml · nonDerivative · entry 4

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,102

F4 · shares: On June 7, 2024, the reporting person transferred 40,719 shares of Medifast common stock to the Dan and Allyson as Joint Tenants account for no consideration. The reporting person owns the account as a joint tenant with his spouse. The reporting person and his spouse remain the beneficial owners of the securities held by the account.

SEC source: 0001628280-25-004896 · wk-form5_1739309448.xml · nonDerivative · entry 2

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Dan and Allyson as Joint Tenants

Disclosed balance after: 108,598.352

F3 · ownership.nature: These shares are directly owned by a joint account of which the reporting person owns as a joint tenant with his spouse.

SEC source: 0001628280-25-004896 · wk-form5_1739309448.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · The Dan and Allyson Family Irrevocable Trust

Disclosed balance after: 0

F1 · shares: On April 26, 2024, the reporting person transferred 108,598.352 shares of Medifast common stock to the Dan and Allyson as Joint Tenants account for no consideration. The reporting person owns the account as a joint tenant with his spouse.

F2 · ownership.nature: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.

SEC source: 0001628280-24-011975 · wk-form4_1710886551.xml · nonDerivative · entry 3

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,534

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-011975 · wk-form4_1710886551.xml · nonDerivative · entry 2

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,958

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-011975 · wk-form4_1710886551.xml · nonDerivative · entry 1

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,077

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-011974 · wk-form4_1710886523.xml · nonDerivative · entry 2

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,917

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-011974 · wk-form4_1710886523.xml · nonDerivative · entry 1

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-011973 · wk-form4_1710886485.xml · nonDerivative · entry 3

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,821

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-011973 · wk-form4_1710886485.xml · nonDerivative · entry 2

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,680

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-011973 · wk-form4_1710886485.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,622

F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

SEC source: 0001628280-24-011544 · wk-form4_1710538400.xml · nonDerivative · entry 1

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,150

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001628280-24-011543 · wk-form4_1710538353.xml · nonDerivative · entry 1

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,051

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001628280-24-011542 · wk-form4_1710538304.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,230

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001628280-24-010641 · wk-form4_1710278284.xml · derivative · entry 4

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,300 shares

Expires 2026-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.

SEC source: 0001628280-24-010641 · wk-form4_1710278284.xml · nonDerivative · entry 3

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,784.707

F1 · price: The price reported in Column 4 is an average price. These shares were acquired in multiple transactions at prices ranging from $39.38 to $39.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-010641 · wk-form4_1710278284.xml · nonDerivative · entry 2

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,537.707

SEC source: 0001628280-24-010641 · wk-form4_1710278284.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,837.707

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-24-005407 · wk-form4_1708123962.xml · nonDerivative · entry 2

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,143

SEC source: 0001628280-24-005407 · wk-form4_1708123962.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,614

F1 · price: 8,243 Performance Stock Units were granted on March 17, 2021, and vested on December 31, 2023 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 14, 2024 and the shares were released on February 14, 2024.

SEC source: 0001628280-24-005405 · wk-form4_1708123857.xml · nonDerivative · entry 2

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,432

SEC source: 0001628280-24-005405 · wk-form4_1708123857.xml · nonDerivative · entry 1

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,080

F1 · price: 1,164 Performance Stock Units were granted on March 17, 2021, and vested on December 31, 2023 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 14, 2024 and the shares were released on February 14, 2024.

SEC source: 0001628280-23-038378 · wk-form4_1699579205.xml · nonDerivative · entry 1

Thomas Andrea B · CIK 0001779769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,253.123

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-038377 · wk-form4_1699579192.xml · nonDerivative · entry 1

Hoer Michael A. · CIK 0001743755 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,375.473

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-038376 · wk-form4_1699579176.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,537.707

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-038375 · wk-form4_1699579158.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,783.647

F3 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-038374 · wk-form4_1699579144.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,812.918

Underlying: Common Stock · 48.441 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001628280-23-038375 · wk-form4_1699579158.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey Brown Living Trust

Disclosed balance after: 4,232.967

F1 · shares: These shares were acquired by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F2 · ownership.nature: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.

SEC source: 0001645615-23-000004 · primary_doc.xml · nonDerivative · entry 1

HALLQUIST CONSTANCE J. · CIK 0001645615 · Former Director

10b5-1 filing: No plan indicated

Ownership: Indirect · (1)

Disclosed balance after: 2,152

SEC source: 0001628280-23-032392 · wk-form4_1694811703.xml · nonDerivative · entry 1

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,486

F1 · shares: These shares were withheld to satisfy the tax withholding obligations upon vesting of an equity award.

F2 · price: This equity award vested on September 13, 2023. The price used for withholding was the closing sales price of the vesting date.

SEC source: 0001628280-23-029696 · wk-form4_1692223114.xml · nonDerivative · entry 3

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 0.638

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.03 to $90.93, inclusive.

F2 · ownership.nature: These shares were held by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

SEC source: 0001628280-23-029696 · wk-form4_1692223114.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 13,330.638

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.36 to $89.96, inclusive.

F2 · ownership.nature: These shares were held by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

SEC source: 0001628280-23-029696 · wk-form4_1692223114.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 23,162.638

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.50 to $92.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3, and 4 herein.

F2 · ownership.nature: These shares were held by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.